Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
27,691,200
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
16,048,764
-
Shares change
-
+1,106,621
-
Total reported value, excl. options
-
$101,424,546
-
Value change
-
+$7,283,101
-
Number of buys
-
37
-
Number of sells
-
-24
-
Price
-
$6.32
Significant Holders of FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) as of Q4 2024
75 filings reported holding FENC - FENNEC PHARMACEUTICALS INC. - Common Shares as of Q4 2024.
FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16,048,764 shares
of 27,691,200 outstanding shares and own 58% of the company stock.
Largest 10 shareholders include Southpoint Capital Advisors LP (4,077,214 shares), Sonic GP LLC (2,407,357 shares), Solas Capital Management, LLC (2,250,919 shares), Rosalind Advisors, Inc. (1,259,876 shares), BlackRock, Inc. (1,226,332 shares), DG Capital Management, LLC (1,114,692 shares), VANGUARD GROUP INC (969,754 shares), HARBERT FUND ADVISORS, INC. (466,869 shares), MORGAN STANLEY (346,376 shares), and STATE STREET CORP (339,713 shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.